Amreen Husain
Impact in
- Reproductive Medicine top 0.2%
- Ovarian cancer diagnosis and treatment
- Obstetrics and Gynecology top 0.2%
- Endometrial and Cervical Cancer Treatments
Papers in
-
- Ovarian cancer diagnosis and treatment 28
-
- Endometrial and Cervical Cancer Treatments 20
- Co-authors
- Véronique Dièras (6 shared papers)Luciana Molinero (6 shared papers)Peter Schmid (6 shared papers)Sylvia Adams (6 shared papers)Hiroji Iwata (6 shared papers)Sherene Loi (6 shared papers)Hope S. Rugo (5 shared papers)Carlos H. Barrios (5 shared papers)
- Journals
- Gynecologic Oncology (22 papers)Journal of Clinical Oncology (11 papers)Obstetrics and Gynecology (6 papers)American Journal of Obstetrics and Gynecology (3 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Amreen Husain
72 papers receiving 8.2k citations
Amreen Husain's Hit Papers
Peers
Comparison fields: 5 of 109
- Reproductive Medicine 1.8k
- Obstetrics and Gynecology 1.3k
- Oncology 3.8k
- Cancer Research 1.0k
- Immunology 1.2k
Countries citing papers authored by Amreen Husain
This map shows the geographic impact of Amreen Husain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amreen Husain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amreen Husain more than expected).
Fields of papers citing papers by Amreen Husain
This network shows the impact of papers produced by Amreen Husain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amreen Husain. The network helps show where Amreen Husain may publish in the future.
Co-authors
The 25 scholars most cited alongside Amreen Husain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer Hit paper breakdown → | 2018 | 3084 |
| 2 | OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Hit paper breakdown → | 2012 | 981 |
| 3 | Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2019 | 877 |
| 4 | 2006 | 316 | |
| 5 | BRCA1 up-regulation is associated with repair-mediated resistance to cis-diamminedichloroplatinum(II). | 1998 | 232 |
| 6 | 2015 | 224 | |
| 7 | Atezolizumab and nab-Paclitaxel in Advanced Triple-Negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study Hit paper breakdown → | 2021 | 214 |
| 8 | 2008 | 164 | |
| 9 | 2007 | 138 | |
| 10 | 2006 | 124 | |
| 11 | 2006 | 115 | |
| 12 | 2007 | 111 | |
| 13 | 2007 | 107 | |
| 14 | 2006 | 105 | |
| 15 | 1996 | 104 | |
| 16 | Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy. | 2000 | 104 |
| 17 | 2007 | 84 | |
| 18 | 2017 | 83 | |
| 19 | 2004 | 75 | |
| 20 | 2008 | 74 |
About Amreen Husain
Amreen Husain is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 74 papers that have together received 8.3k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (28 papers), Endometrial and Cervical Cancer Treatments (20 papers), Renal cell carcinoma treatment (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Cancer Genomics and Diagnostics (4 papers), Advanced Breast Cancer Therapies (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and DNA Repair Mechanisms (3 papers). The work is most often cited by research in Reproductive Medicine (1.8k citations), Obstetrics and Gynecology (1.3k citations), Oncology (3.8k citations), Cancer Research (1.0k citations) and Immunology (1.2k citations). Amreen Husain has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Véronique Dièras, Luciana Molinero, Peter Schmid, Sylvia Adams, Hiroji Iwata, Sherene Loi, Hope S. Rugo, Carlos H. Barrios, Eric P. Winer and Jane Yuet Ching Hui. Their work appears in journals such as Gynecologic Oncology, Journal of Clinical Oncology, Obstetrics and Gynecology, American Journal of Obstetrics and Gynecology and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.